Retromer levels in animal models can be increased by treatment with these molecules to protect against neurodegeneration in an ALS model [101] and decrease amyloid-precursor protein (APP) processing in a Alzheimer's model [102]. This evidence concerns the gene APP and amyotrophic lateral sclerosis.